Bal Pharma Ltd.
BSE: 524824 | Sector: Health care |
NSE: BALPHARMA | ISIN Code: INE083D01012 |
BSE 00:00 | 27 May | 99.25 |
-1.25 (-1.24%) |
OPEN
102.15 |
HIGH
102.15 |
LOW
98.50 |
NSE 00:00 | 27 May | 99.45 |
-1.15 (-1.14%) |
OPEN
101.55 |
HIGH
104.00 |
LOW
97.50 |
OPEN | 102.15 |
PREVIOUS CLOSE | 100.50 |
VOLUME | 2777 |
52-Week high | 148.50 |
52-Week low | 88.00 |
P/E | 15.18 |
Mkt Cap.(Rs cr) | 155 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Bal Pharma Ltd. (BALPHARMA) - Share Holding
(in %) | Apr 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 |
Promoter & Group | |||||
Foreign | 4.21 | 4.42 | 4.42 | 4.42 | 4.42 |
Indian | 47.79 | 45.15 | 45.15 | 42.45 | 40.42 |
Total Promoters | 52.00 | 49.57 | 49.57 | 46.87 | 44.84 |
Non Promoter | |||||
Institutions | 0.30 | 0.31 | 0.31 | 0.15 | 0.00 |
Financial Institutions / Banks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Foreign Institutional Investors | 0.30 | 0.31 | 0.31 | 0.15 | 0.00 |
Insurance Companies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Mutual Funds / UTI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Institution | 47.71 | 50.12 | 50.12 | 52.98 | 55.16 |
Indian Public | 31.30 | 32.88 | 32.97 | 35.73 | 38.37 |
Others | 16.41 | 17.24 | 17.15 | 17.25 | 16.79 |
Total Non Promoter | 48.01 | 50.43 | 50.43 | 53.13 | 55.16 |
Total Promoter & Non Promoter | 100.01 | 100.00 | 100.00 | 100.00 | 100.00 |
Custodians | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Grand Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices